Memantine recalls

The FDA has published 7 recalls involving Memantine since 2019. The latest was reported on 22 Apr 2026. Most were for potency & assay. The Harvard Drug Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls7since 2019
Last 12 months1reported
Class I00% of total
Ongoing1latest 22 Apr 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 4 57%Class III 3 43%

Why memantine is recalled

By year

Ongoing memantine recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMemantine Hydrochloride Extended-Release, Capsules, 7 mg recalledMemantine HydrochlorideThe Harvard Drug GroupPotency & AssayNationwide

All memantine recalls, newest first

7 total

Should you stop taking Memantine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.